| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 181.971 | 83 |
| GSM780708 | Untreated after 4 days (C2_1) | 205.854 | 84 |
| GSM780709 | Untreated after 4 days (C3_1) | 222.094 | 85 |
| GSM780719 | Untreated after 4 days (C1_2) | 171.446 | 82 |
| GSM780720 | Untreated after 4 days (C2_2) | 224.004 | 85 |
| GSM780721 | Untreated after 4 days (C3_2) | 220.129 | 85 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 208.625 | 84 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 172.844 | 82 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 184.98 | 83 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 219.111 | 84 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 181.573 | 83 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 173.677 | 82 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 179.965 | 82 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 204.268 | 84 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 183.386 | 83 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 172.017 | 82 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 181.037 | 83 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 190.307 | 83 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 208.227 | 84 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 174.395 | 82 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 198.552 | 83 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 192.937 | 83 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 206.462 | 84 |